World Journal of Surgery · 2018 · 64 citations · 31 references
MedicinePerioperative MedicineSurgeryEnhanced Recovery After SurgeryHepatologyTransplant SurgeryEnhanced Recovery OutcomesFunctional RecoveryLiver RegenerationLiver TransplantationPostoperative Recovery ImprovementTransplant RejectionDeceased Donor Liver TransplantationEnhanced Recovery After Liver TransplantationFeasibility Study DesignHepatic RecoveryLiver Transplant Care
BACKGROUND: Enhanced Recovery After Surgery (ERAS) programmes after surgery are effective in reducing length of stay, functional recovery and complication rates in liver surgery (LS) with the indirect advantage of reducing hospitalisation costs. Preoperative comorbidities, challenging surgical procedures and complex post-operative management are the points that liver transplantation (LT) shares with LS. Nevertheless, there is little evidence regarding the feasibility and safety of ERAS programmes in LT. METHODS: We designed a pilot, small-scale, feasibility study to assess the impact on hospital stay, protocol compliance and safety of an ERAS programme tailored for LT. The ERAS arm was compared with a 1:2 match paired control arm with similar characteristics. All patients with MELD <25 were included. A dedicated LT-tailored protocol was derived from publications on ERAS liver surgery. RESULTS: Ten patients were included in the Fast-Trans arm. It was observed a 47% reduction of the total LOS, as compared to the control arm: 9.5 (9.0-10.5) days versus 18.0 (14.3-24.3) days, respectively, p <0.001. The protocol achieved 72.9% compliance. No differences were observed in terms of post-operative complications or readmission rates after discharge between the two arms. Overall, it was observed a reduction of length of stay in ICU and surgical ward in the Fast-Trans arm compared with the control arm. CONCLUSION: Considered the main points in common between LS and LT, this small-scale study suggests that the application of an ERAS programme tailored to the LT setting is feasible. Further testing will be appropriate to generalise these findings.
31
How We Design Feasibility Studies
Deborah J. Bowen, Matthew W. Kreuter, Bonnie Spring et al. · American Journal of Preventive Medicine · 2009 · 3.8K citations · Full text